ZA200708215B - Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number: ZA200708215B
Authority: ZA; South Africa
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; tetracyclic compounds; tetracyclic
Prior art date: 2006-09-26

Application number

ZA200708215A

Other languages

English (en)

Inventor

Peglion Jean-Louis

Poitevin Christophe

Millan Mark

Brocco Mauricette

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-26

Filing date

2007-09-26

Publication date

2008-09-25

2007-09-26 Application filed by Servier Lab filed Critical Servier Lab

2008-09-25 Publication of ZA200708215B publication Critical patent/ZA200708215B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ZA200708215A 2006-09-26 2007-09-26 Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them ZA200708215B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0608413A FR2906249B1 (fr)	2006-09-26	2006-09-26	Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
ZA200708215B true ZA200708215B (en)	2008-09-25

Family

ID=37877016

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200708215A ZA200708215B (en)	2006-09-26	2007-09-26	Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (31)

Country	Link
US (1)	US7470683B2 (xx)
EP (1)	EP1905775B1 (xx)
JP (1)	JP2008100995A (xx)
KR (1)	KR100934315B1 (xx)
CN (1)	CN101153043B (xx)
AR (1)	AR062950A1 (xx)
AT (1)	ATE480544T1 (xx)
AU (1)	AU2007219281A1 (xx)
BR (1)	BRPI0703655A2 (xx)
CA (1)	CA2603274C (xx)
CY (1)	CY1110799T1 (xx)
DE (1)	DE602007009004D1 (xx)
DK (1)	DK1905775T3 (xx)
EA (1)	EA013406B1 (xx)
ES (1)	ES2351945T3 (xx)
FR (1)	FR2906249B1 (xx)
GE (1)	GEP20104877B (xx)
HR (1)	HRP20100605T1 (xx)
MA (1)	MA29371B1 (xx)
MX (1)	MX2007011524A (xx)
MY (1)	MY142517A (xx)
NO (1)	NO20074889L (xx)
NZ (1)	NZ561905A (xx)
PL (1)	PL1905775T3 (xx)
PT (1)	PT1905775E (xx)
RS (1)	RS51418B (xx)
SG (1)	SG141382A1 (xx)
SI (1)	SI1905775T1 (xx)
UA (1)	UA96125C2 (xx)
WO (1)	WO2008037888A2 (xx)
ZA (1)	ZA200708215B (xx)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4420480A (en) *	1981-11-20	1983-12-13	Merck & Co., Inc.	Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) *	1981-11-20	1986-05-20	Merck Co.	Hexahydronaphth (1,2-b) -1,4 -oxazines
FR2721027B1 (fr) *	1994-06-08	1996-07-19	Adir	Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR2741074B1 (fr) *	1995-11-09	1997-12-19	Adir	Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2767825A1 (fr)	1997-09-01	1999-02-26	Adir	Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht°1,2-b!-1, 4-oxazines disubstituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2845994B1 (fr) *	2002-10-18	2006-05-19	Servier Lab	Nouveaux derives de benzo[e][1,4]oxazino[3,2-g]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

2006
- 2006-09-26 FR FR0608413A patent/FR2906249B1/fr not_active Expired - Fee Related
2007
- 2007-09-11 MA MA30219A patent/MA29371B1/fr unknown
- 2007-09-19 MX MX2007011524A patent/MX2007011524A/es unknown
- 2007-09-21 KR KR1020070096525A patent/KR100934315B1/ko not_active Expired - Fee Related
- 2007-09-24 SG SG200708582-2A patent/SG141382A1/en unknown
- 2007-09-24 AR ARP070104197A patent/AR062950A1/es unknown
- 2007-09-24 EA EA200701807A patent/EA013406B1/ru not_active IP Right Cessation
- 2007-09-24 AU AU2007219281A patent/AU2007219281A1/en not_active Abandoned
- 2007-09-24 CN CN2007101617348A patent/CN101153043B/zh not_active Expired - Fee Related
- 2007-09-25 MY MYPI20071605A patent/MY142517A/en unknown
- 2007-09-25 PL PL07291135T patent/PL1905775T3/pl unknown
- 2007-09-25 RS RSP-2010/0420A patent/RS51418B/sr unknown
- 2007-09-25 DK DK07291135.7T patent/DK1905775T3/da active
- 2007-09-25 WO PCT/FR2007/001557 patent/WO2008037888A2/fr not_active Ceased
- 2007-09-25 AT AT07291135T patent/ATE480544T1/de active
- 2007-09-25 ES ES07291135T patent/ES2351945T3/es active Active
- 2007-09-25 SI SI200730350T patent/SI1905775T1/sl unknown
- 2007-09-25 US US11/904,006 patent/US7470683B2/en not_active Expired - Fee Related
- 2007-09-25 EP EP07291135A patent/EP1905775B1/fr active Active
- 2007-09-25 NZ NZ561905A patent/NZ561905A/en not_active IP Right Cessation
- 2007-09-25 DE DE602007009004T patent/DE602007009004D1/de active Active
- 2007-09-25 GE GEAP200710284A patent/GEP20104877B/en unknown
- 2007-09-25 PT PT07291135T patent/PT1905775E/pt unknown
- 2007-09-26 UA UAA200710656A patent/UA96125C2/ru unknown
- 2007-09-26 JP JP2007248428A patent/JP2008100995A/ja not_active Ceased
- 2007-09-26 NO NO20074889A patent/NO20074889L/no not_active Application Discontinuation
- 2007-09-26 BR BRPI0703655-8A patent/BRPI0703655A2/pt not_active IP Right Cessation
- 2007-09-26 ZA ZA200708215A patent/ZA200708215B/xx unknown
- 2007-09-26 CA CA2603274A patent/CA2603274C/fr not_active Expired - Fee Related
2010
- 2010-09-24 CY CY20101100862T patent/CY1110799T1/el unknown
- 2010-11-10 HR HR20100605T patent/HRP20100605T1/hr unknown

Also Published As

Publication number	Publication date
HK1119163A1 (en)	2009-02-27
GEP20104877B (en)	2010-01-11
CA2603274A1 (fr)	2008-03-26
PT1905775E (pt)	2010-11-17
CA2603274C (fr)	2010-08-31
KR20080028316A (ko)	2008-03-31
SI1905775T1 (sl)	2010-10-29
UA96125C2 (ru)	2011-10-10
JP2008100995A (ja)	2008-05-01
KR100934315B1 (ko)	2009-12-29
ATE480544T1 (de)	2010-09-15
PL1905775T3 (pl)	2011-03-31
FR2906249B1 (fr)	2008-12-19
DK1905775T3 (da)	2010-12-06
EP1905775A1 (fr)	2008-04-02
WO2008037888A2 (fr)	2008-04-03
AR062950A1 (es)	2008-12-17
CN101153043A (zh)	2008-04-02
HRP20100605T1 (hr)	2010-12-31
DE602007009004D1 (de)	2010-10-21
CN101153043B (zh)	2011-01-19
FR2906249A1 (fr)	2008-03-28
MA29371B1 (fr)	2008-04-01
CY1110799T1 (el)	2015-06-10
RS51418B (sr)	2011-02-28
AU2007219281A1 (en)	2008-04-10
EA200701807A1 (ru)	2008-04-28
EP1905775B1 (fr)	2010-09-08
MX2007011524A (es)	2009-02-16
NO20074889L (no)	2008-03-27
NZ561905A (en)	2009-01-31
US7470683B2 (en)	2008-12-30
EA013406B1 (ru)	2010-04-30
US20080076765A1 (en)	2008-03-27
SG141382A1 (en)	2008-04-28
MY142517A (en)	2010-12-15
WO2008037888A3 (fr)	2008-06-12
ES2351945T3 (es)	2011-02-14
BRPI0703655A2 (pt)	2009-05-19

Similar Documents

Publication	Publication Date	Title
ZA200704957B (en)	2008-08-27	Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
SG151172A1 (en)	2009-04-30	1,2,4,5-tetrahydro-3h-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them
AP3024A (en)	2014-11-30	New Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
IL193340A0 (en)	2009-05-04	Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
SG131857A1 (en)	2007-05-28	δD-CRYSTALLINE FORM OF IV ABRADINE HYDROCHLORIDE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
IL200128A0 (en)	2010-04-15	New tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them
IL193341A0 (en)	2009-05-04	Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
IL193339A0 (en)	2009-05-04	Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL207183A0 (en)	2010-12-30	New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
IL205710A (en)	2013-07-31	History of Spiro [Pipyridine-Benzopyran] Pharmaceuticals Containing Them, Methods of Preparing and Using Their @
EP1871363A4 (en)	2009-01-21	COMBINED STAGE PROCESS FOR PHARMACEUTICAL COMPOSITIONS
SG126113A1 (en)	2006-10-30	Indany-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200806399B (en)	2009-11-25	Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
ZA200603810B (en)	2007-08-29	Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200704955B (en)	2008-08-27	Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200704956B (en)	2008-08-27	Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000025B (en)	2011-04-28	New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
ZA200603809B (en)	2007-08-29	Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
IL206885A0 (en)	2010-12-30	New chromene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200602872B (en)	2007-06-27	Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
AP2009004891A0 (en)	2009-06-30	New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000024B (en)	2011-04-28	New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
ZA200800833B (en)	2009-04-29	New 1H-indole-pyridinecarboxamide and 1H-indolepiperidinecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200708215B (en)	2008-09-25	Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them
GB0612695D0 (en)	2006-08-09	Process for preparing a solid dosage form